Cargando…
Methotrexate-induced acute cardiotoxicity requiring veno-arterial extracorporeal membrane oxygenation support: a case report
BACKGROUND: Methotrexate is an antifolate antimetabolite that inhibits the activity of dihydrofolate reductase by acting as a false substrate, which leads to defects of DNA synthesis, specifically the inhibition of purine and pyrimidine synthesis. Thus, methotrexate is a powerful agent for treating...
Autores principales: | Shah, Sareena, Haeger-Overstreet, Kristen, Flynn, Brigid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707053/ https://www.ncbi.nlm.nih.gov/pubmed/36443884 http://dx.doi.org/10.1186/s13256-022-03644-9 |
Ejemplares similares
-
Outcomes of patients with acute respiratory failure on veno-venous extracorporeal membrane oxygenation requiring additional circulatory support by veno-venoarterial extracorporeal membrane oxygenation
por: Erlebach, Rolf, et al.
Publicado: (2022) -
Fundamentals of weaning veno-arterial and veno-venous extracorporeal membrane oxygenation
por: Tsiouris, Athanasios, et al.
Publicado: (2023) -
Rat model of veno-arterial extracorporeal membrane oxygenation
por: Ali, Ayyaz A, et al.
Publicado: (2014) -
Cardiac Tamponade in a Patient Supported by Veno-arterial Extracorporeal Membrane Oxygenation
por: Seelhammer, Troy G., et al.
Publicado: (2022) -
Axillary artery cannulation for veno-arterial extracorporeal membrane oxygenation support in cardiogenic shock
por: Ohira, Suguru, et al.
Publicado: (2020)